Monthly Archives: July 2009

Pharma Accused of Keeping Good Generics Down

Image via Wikipedia The European Commission has accused the pharmaceutical industry of delaying the entry of generic drugs to the market. As a result, it intends to step up its scrutiny of the sector under EU antitrust law. “We must have more competition and less red tape in pharmaceuticals,” claimed Competition Commissioner Neelie Kroes. “The inquiry [...]
Posted in Global, News | Tagged , , , , , , , | 1 Comment

Daiichi Sankyo Chief Talks Effient

FDA, late Friday, approved Daiichi Sankyo and Eli Lilly’s Effient (prasugrel), a blood thinner designed to lower the chance of blood clots in patients undergoing angioplasty. The drug received a black box warning from the get go, warning doctors of an increased risk of bleeding. However, the fact that the two companies now have a [...]
Posted in News, Strategy, Technology | Tagged , , , , , , | 2 Comments

Novo Nordisk Launches Branded Twitter Campaign

Novo Nordisk, last week, officially launched its branded Twitter site “Race with Insulin” to keep patients aware of the day-to-day happenings in the life of indie racer Charlie Kimball. Using the social networking tool, Kimball openly talks about what it’s like to live with Type 1 diabetes and tweets about using Novo Nordisk’s Levemir (insulin detemir) [...]
Posted in E-Media | Tagged , , , , , , , | 3 Comments

Caraco Pharma Eliminates 350 Jobs

Caraco Pharmaceutical Labs announced on Monday that it will eliminate half its workforce—approximately 350 positions—but added that the number could grow as the generics firm deals with a voluntary manufacturing shutdown stemming from an FDA investigation. Last month, US marshalls seized an undisclosed amount of drug ingredients and products in a raid at the company’s Michigan [...]
Posted in Strategy | Tagged , , , , , , , , | 1 Comment

Playing Spot the Healthcare Lobbyist

National Public Radio has posted an interesting, possibly provocative, but certainly confusing, item on its website. It’s a photograph taken late last month during the first Congressional hearings on the trillion-dollar healthcare reform legislation. Actually, it’s not just a photograph but a panoramic, four-frame, interactive feature complete with cutesy rollover icons. More importantly, it shows not [...]
Posted in Regulatory | Tagged , , , | 2 Comments